John Kuch
Net worth: 2 M $ as of 2024-04-29
Network origin in John Kuch first degree
Entity | Entity type | Industry | |
---|---|---|---|
36
| Public Company | Biotechnology | 36 |
Pricewaterhouse & Co.
2
| Extinct | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Kuch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Chief Administrative Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | President General Counsel | |
XOMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Financial ConglomeratesFinance Raymond James & Associates, Inc. (RJA) is a registered broker-dealer headquartered in St. Petersburg, Florida. The firm was founded in 1962 and is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a diversified holding company. RJA offers a full array of capital markets services, strategic advice and planning for institutional investors. | Financial Conglomerates | Analyst-Equity | |
SEQUENOM, INC. | Medical Specialties | Chief Executive Officer General Counsel | |
DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Biotechnology | Corporate Officer/Principal | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Macquarie Capital (USA), Inc.
Macquarie Capital (USA), Inc. Investment Banks/BrokersFinance Founded in 2001, Macquarie Capital (USA), Inc. is a registered broker/dealer located in New York City. The firm is a subsidiary of Macquarie Bank Ltd. (ASX: MBL). They provide coverage of the following industries: resources, healthcare, security/defense, transportation, financial services, retail/consumer products, TMET (telecommunications, media, entertainment and technology), oil & gas, diversified manufacturing/distribution and infrastructure/utilities. Macquarie Capital (USA), Inc. is a member of FINRA. | Investment Banks/Brokers | Analyst-Equity | |
The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
The Pennsylvania State University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Princeton University | College/University | Graduate Degree Graduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
University of California, Davis | College/University | Doctorate Degree Doctorate Degree | |
MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
INMUNE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
Clinical Micro Sensors, Inc.
Clinical Micro Sensors, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Roche Holding AG, Clinical Micro Sensors, Inc. is a company that manufactures instruments used in genetic diagnostics testing. The company is based in Pasadena, CA. The company was founded by Jon Faiz Kayyem. Clinical Micro Sensors was acquired by Osmetech Ltd. from Motorola, Inc. on August 10, 2005 for $2.45 million. | Electronic Equipment/Instruments | Director/Board Member Chief Operating Officer | |
GENE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Biotechnology | Director of Finance/CFO | |
The State University of New York | College/University | Undergraduate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member | |
Amgen International AG | Director of Finance/CFO | ||
Horwath Velez & Co. PSC
Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
United States | 49 |
Switzerland | 2 |
Sectoral
Health Technology | 29 |
Consumer Services | 15 |
Finance | 4 |
Commercial Services | 3 |
Electronic Technology | 2 |
Operational
Director/Board Member | 157 |
Corporate Officer/Principal | 118 |
Independent Dir/Board Member | 50 |
Undergraduate Degree | 35 |
Chief Tech/Sci/R&D Officer | 28 |
Most connected contacts
Insiders | |
---|---|
Jonathan Fleming | 36 |
Lori Kunkel | 27 |
Bruce Carter | 25 |
Robert F. Baltera | 23 |
Christopher Krueger | 20 |
Alan Montgomery | 18 |
Atul Saran | 17 |
Yael Elad | 17 |
Hal R. Werner | 17 |
Ellen Feigal | 15 |
James Young | 15 |
Harry Stylli | 14 |
Yujiro Hata | 14 |
John Stafford | 14 |
Edgardo Baracchini | 13 |
- Stock Market
- Insiders
- John Kuch
- Company connections